Around 80–90% of adenoid cystic carcinomas (AdCC) reveal MYB or MYBL1 activation by gene fusion, leading to overexpression of MYB-NFIB or MYBL1-NFIB fusion protein, respectively [3, 7, 8]. This evidence concerns the gene NFIB and adenoid cystic carcinoma.